Skip to content
Back to Investors
LifeX Ventures

LifeX Ventures

Venture Capital

LifeX Ventures is a New York-based venture capital firm investing in software and artificial intelligence solutions across the health and climate sectors.

Portfolio

2

companies

By category

  • BioTech£11.5M
  • MedTech£6.5M

By location

  • London£18.0M

Portfolio companies

Hypervision Surgical

Hypervision Surgical

Hypervision Surgical develops an advanced surgical imaging and data analytics platform.

IB

IMU Biosciences

Mapping the human immune system through advanced blood analysis.


Team

Iñaki Berenguer

Iñaki Berenguer

Founding Partner

Iñaki is CEO and co-founder of MITO AI and managing partner at LifeX Ventures, alongside board and founding roles across technology and photonics ventures.

LinkedIn

Recent investments

Series A
£11.5M

The financing round was led by Molten Ventures with backing from LifeX Ventures and private individuals.

"With our technology, we’re building the world’s largest immune data assets across health and disease, which allows us to perform analyses with a level of depth and granularity that was previously unthinkable. This systems-level approach to understanding immune function enables us to look at the bigger picture rather than just focusing on individual disease-associated parameters. Our goal is to revolutionise precision medicine, improving its effectiveness, reducing failure rates in clinical trials, and making these therapies more viable in the long run."
— Adam Laing, President and Chief Scientific Officer